No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
FDA Grants Orphan Drug Designation for Zai Lab’s ZL-1310 for SCLC
On 22 January 2025, Zai Lab announced that the US FDA has granted Orphan Drug Designation (ODD) to ZL-1310, a potential highly active first-in-class DLL3 antibody-drug conjugate, for the